Location History:
- Aarhus, DK (2006)
- Odense, DK (2011)
- Artus C., DK (2015)
- Aarhus C, DK (2006 - 2019)
Company Filing History:
3 out of 3 
1 out of 1,746 
1 out of 1 Years Active: 2006-2019
Title: The Innovations of Michael Toft Overgaard in Biotech Fields
Introduction
Michael Toft Overgaard is a prominent inventor based in Aarhus C, Denmark. With four patents to his name, he has significantly contributed to the field of biotechnology. His innovations focus primarily on pregnancy-associated plasma protein A2 (PAPP-A2), a crucial biomarker in various medical applications.
Latest Patents
Overgaard’s latest patents revolve around PAPP-A2. One demonstrates the provision of PAPP-A2, detailing its nucleotide and amino acid sequences. This patent includes the development of antisense molecules, expression vectors for producing purified PAPP-A2, and antibodies that bind specifically to this protein. Additionally, the invention encompasses hybridization probes or oligonucleotides for detecting PAPP-A2-encoding nucleotide sequences, genetically engineered host cells for PAPP-A2 expression, and methods to screen for pathologies in both pregnant and non-pregnant patients. Similarly, his other patent regarding PAPP-A2 polynucleotides includes similar elements aimed at enhancing the detection and understanding of altered focal proliferation states involving PAPP-A2 levels in patients.
Career Highlights
Throughout his career, Michael Toft Overgaard has worked with reputable organizations such as Como Biotech Aps and Mayo Foundation for Medical Education and Research. His work in these esteemed institutions has bolstered his understanding and expertise in biotechnological innovations, particularly those related to reproductive health.
Collaborations
Collaboration plays a vital role in Overgaard’s innovative endeavors. He has worked alongside skilled professionals such as Claus Oxvig and Cheryl A. Conover. These partnerships have contributed to the successful development of his patented inventions, demonstrating the importance of teamwork in advancing scientific discovery.
Conclusion
Michael Toft Overgaard's contributions to the biotechnology sector through his patents on pregnancy-associated plasma protein A2 illustrate the intersection of innovation and medical research. His dedication to enhancing patient care through scientific advancements continues to shape our understanding of important health issues, positioning him as a notable inventor in his field.